Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 1999

View Archived Issues

Alexion advances MI product, UniGraft

ImClone Systems files IND in U.S. for antiangiogenic agent

Progress in proceedings concerning Celltech Chiroscience and Medeva merger

Pivotal trials of Optison ultrasound imaging agent begin in Japan

Pharmos seeks approval for Loterox in the U.K.

Genentech's rhuMAb-VEGF will move to phase III study

WHO takes over to ensure continued availability of antitrypanosomal agent

Searle patents new series of p38 MAP kinase inhibitors for inflammation

Another megamerger proposed: Pharmacia & Upjohn and Monsanto

Nonpeptide agents which mimic peptide T binding to CD4 cell receptors as new treatments for HIV

Synthetic immunogens useful for preparation of HPV preventive vaccine

Preclinical studies validate Nabi's novel approach to treating and preventing nicotine addiction

Novel dopaminergic agents synthesized and tested at AHP

Inhibitors of CPT-I from Sigma-Tau useful for hyperglycemic states, cardiovascular disorders

Roberts launches emergency contraceptive in Canada

Glaxo Wellcome files for approval of first triple combination anti-HIV therapy

PPG superior to nonselective mGluR agonists in audiogenic seizure model

Phase I clinical trial initiated with OSI's second anticancer agent

Remacemide for resistant epilepsy: preliminary data from meta-analysis

German launch announced for flu drug

New class I mGluR antagonist prevents seizure-induced hippocampal damage

Swiss regulatory authorities grant Visudyne Therapy its first approval

Add-on stiripentol produces high response rate in intractable epilepsy syndrome

Tetrapeptide with potent antiinflammatory, antiarthritic effects emerges from India

Warner-Lambert files IND for oral calcitonin product for osteoporosis

New antiplatelet pyridazinones presented by Chinese university investigators

Benzimidazole antidiabetic agent advances through the pipeline in Japan and overseas

NicOx commences phase IIa trial with treatment for Paget's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...